Literature DB >> 13845008

Chloroquine compared with chloroquine and emetine combined in ameblic liver abscess.

A J WILMOT, S J POWELL, E B ADAMS.   

Abstract

Entities:  

Keywords:  AMEBIASIS/therapy; CHLOROQUINE/therapy; EMETINE/therapy; LIVER ABSCESS/therapy

Mesh：

Substances：

Year:  1959        PMID： 13845008     DOI： 10.4269/ajtmh.1959.8.623

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  8 in total

Review 1.  THE CONTROLLED THERAPEUTIC TRIAL IN GASTROENTEROLOGY.

Authors:  S C TRUELOVE; R WRIGHT
Journal:  Am J Dig Dis       Date:  1964-01

Review 2.  Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors:  Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

3.  Drug therapy of amoebiasis.

Authors:  S J Powell
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Amebic liver abscess.

Authors:  R L Johnson; J W Rogers; H H Zinneman
Journal:  Am J Dig Dis       Date:  1968-09

Review 5.  Therapy of amebiasis.

Authors:  S J Powell
Journal:  Bull N Y Acad Med       Date:  1971-05

6.  Emetine hydrochloride and dehydroemetine combined with chloroquine in the treatment of children with amoebic liver abscess.

Authors:  J N Scragg; S J Powell
Journal:  Arch Dis Child       Date:  1968-02       Impact factor: 3.791

7.  Amebiasis. Weekly clinical conference of the section of gastroenterology of the University of Michigan.

Authors:  W A Sodeman
Journal:  Am J Dig Dis       Date:  1971-01

8.  Emetine hydrochloride and chloroquine in the treatment of children with amoebic liver abscess.

Authors:  J N Scragg; S J Powell
Journal:  Arch Dis Child       Date:  1966-10       Impact factor: 3.791
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.